Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Feb 2015

Huang Hsien-Neng, Chiang Ying-Cheng, Cheng Wen-Fang, Chen Chi-An, Lin Ming-Chieh, Kuo Kuan-Ting

Abstract excerpt

Recently, mutations of telomerase reverse transcriptase (TERT) promoter were found in several types of cancer. A few reports demonstrate TERT promoter mutations in ovarian clear cell carcinomas but endometrial clear cell carcinoma has not been studied. The aims of this study were to compare differences of molecular alterations and clinical factors, and identify their prognostic impact in endometrial and ovarian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Kaplan-Meier Estimate

Share to Ovarian Neoplasms

Share to Phosphatidylinositol 3-Kinases

Share to Proportional Hazards Models

Share to Telomerase

Source

Identifiers

PMID: 25081752
DOI: 10.1038/modpathol.2014.93

Genes

TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.PMID 25081752Read ↗

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.Semantic proximity Read ↗

Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival.Semantic proximity Read ↗

Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma.Semantic proximity Read ↗

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.Semantic proximity Read ↗

TERT promoter mutations in clear cell renal cell carcinoma.Semantic proximity Read ↗

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.Semantic proximity Read ↗

Suppressor-type TERT mutations associated with recurrence in ovarian clear cell carcinoma.Semantic proximity Read ↗

Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy.Semantic proximity Read ↗

Molecular characterization of uterine clear cell carcinoma.Semantic proximity Read ↗

Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma.Semantic proximity Read ↗

CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.Semantic proximity Read ↗

<i>WT1</i> and <i>WT1‐AS</i> genes are inactivated by promoter methylation in ovarian clear cell adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.